SCHEMBL8905783

SCHEMBL8905783

OCCCCCCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.65
ALOX15 P16050 2/20 0.65
PNMT P11086 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
PYGL P06737 1/20 0.50
SIGMAR1 Q99720 10/20 0.49
IDO1 P14902 1/20 0.47
HDAC6 Q9UBN7 1/20 0.46
CA2 P00918 1/20 0.44
BCHE P06276 2/20 0.44
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10609252 1.00 IGF1R (0.65) IGF1RALOX15PNMTTAAR1PYGL
SCHEMBL7008253 1.00 IGF1R (0.65) IGF1RALOX15PNMTTAAR1PYGL
SCHEMBL9026682 0.98 IGF1R (0.67) IGF1RALOX15PNMTTAAR1PYGL
SCHEMBL81497 0.92 IGF1R (0.63) IGF1RALOX15PNMTTAAR1PYGL
SCHEMBL9241133 0.83 AHR (0.50) IGF1RALOX15PNMTTAAR1SIGMAR1
SCHEMBL908524 0.83 PNMT (0.61) IGF1RALOX15PNMTTAAR1PYGL
SCHEMBL15689781 0.81 IGF1R (0.47) IGF1RALOX15PNMTTAAR1SIGMAR1
SCHEMBL11332028 0.80 PNMT (0.70) IGF1RALOX15PNMTTAAR1PYGL
SCHEMBL22333700 0.80 SIGMAR1 (0.61) IGF1RALOX15PNMTTAAR1SIGMAR1
SCHEMBL11332990 0.80 PNMT (0.70) IGF1RALOX15PNMTTAAR1PYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698585-A FOR SENILE CATARACT CAUSED BY OXIDATION DISORDER; VISION DEFECTS KIKKOMAN CORPORATION (JP) 1997-12-16 US disclosed
EP-0737476-A2 A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts KIKKOMAN CORPORATION (JP) 1996-10-16 EP disclosed